Literature DB >> 22985731

Bleeding diathesis in Noonan syndrome: is acquired von Willebrand syndrome the clue?

Gesa Wiegand1, Michael Hofbeck, Martin Zenker, Ulrich Budde, Ralf Rauch.   

Abstract

INTRODUCTION: Noonan syndrome (NS) is characterized by dysmorphic facies, short stature and congenital heart defects. Various haemostatic disorders have been described in NS patients, but not all were related to bleeding, which itself is present in up to 65%. Several subgroups of NS - especially those with PTPN11 mutation - are associated with pulmonary stenosis. As it is known that some heart defects are prone to a shear stress related destruction of the von Willebrand factor as an important haemostatic component, we aimed to find out, whether the pulmonary stenosis could be responsible for such a mechanism in NS patients. PATIENTS, METHODS AND
RESULTS: We investigated the haemostatic system in 15 children with genetically proven NS (14 with PTPN11, one with SOS1 mutation). Platelet count, basic coagulation parameters, fibrinogen and antithrombin were normal in all patients, none had a relevant reduction of coagulation factor activities. Five patients had pulmonary valve stenosis with systolic gradients>60 mmHg. In three of them a deficiency of the high molecular weight multimers and a pathologic collagen-binding capacity were detected, suggesting acquired von Willebrand syndrome. Nine of our patients indicated a relevant bleeding diathesis and complained of easy bruising, three reported spontaneous gum bleeding. IN
CONCLUSION: the destruction of the von Willebrand factor could explain the bleeding in some of the NS patients with pulmonary valve stenosis. Our finding is of clinical relevance since most of these patients require either interventional cardiac catheterization or open heart surgery which may be complicated by the haemorrhagic tendency.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22985731     DOI: 10.1016/j.thromres.2012.08.314

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review.

Authors:  Diane J Nugent; Alicia A Romano; Shreya Sabharwal; David L Cooper
Journal:  J Blood Med       Date:  2018-10-23

3.  RASopathies and hemostatic abnormalities: key role of platelet dysfunction.

Authors:  Francesca Di Candia; Valeria Marchetti; Ferdinando Cirillo; Alessandro Di Minno; Carmen Rosano; Stefano Pagano; Maria Anna Siano; Mariateresa Falco; Antonia Assunto; Giovanni Boccia; Gerardo Magliacane; Valentina Pinna; Alessandro De Luca; Marco Tartaglia; Giovanni Di Minno; Pietro Strisciuglio; Daniela Melis
Journal:  Orphanet J Rare Dis       Date:  2021-12-02       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.